Company Announcements

Director/PDMR Shareholding

Source: RNS
RNS Number : 9416S
Physiomics PLC
22 March 2021
 

22 March 2021

Physiomics plc

("Physiomics") or ("the Company")

 

Director Dealing

 

The Company announces that Dr Jim Millen, Chief Executive Officer of Physiomics, has been notified that a brokerage account with Reyker Securities plc ("Reyker") in which he held an interest of 244,641 ordinary shares of 0.4p each in the Company ("Ordinary Shares"), has been closed and transferred to a brokerage account with James Brearley & Sons Limited, for no consideration (the "Transfer").  The Transfer occurred as a result of Reyker entering special administration on 9 October 2019 and the Ordinary Shares subject to the Transfer remain beneficially owned by Dr Millen. Further, Dr Millen understands that 2,354 Ordinary Shares were sold during the administration process to cover certain account charges, although Dr Millen has not been notified of the timing and price of this sale.

 

Accordingly, Dr Millen's holding in the Company is 1,384,393 Ordinary Shares, representing approximately 1.42 per cent. of the Company's issued share capital.

 

 

Enquiries:

 

Physiomics plc                                                  

Dr Jim Millen, CEO

+44 (0)1865 784 980

 

Hybridan LLP (broker)

Claire Louise Noyce

+44 (0) 203 764 2341

 

Strand Hanson Ltd (NOMAD)

James Dance & James Bellman

+44 (0)20 7409 3494

 

 

 

 



NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

James Millen

2

Reason for the notification

a)

Position/status

Director, CEO

b)

Initial notification/ Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Physiomics plc

b)

LEI

213800A71DSZ6ABMTQ91

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary share

 

 

GB00BDR6W943

b)

Nature of the transaction

Disposal and transfer of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Unknown

2,354

N/A

242,287

d)

Aggregated information

-     Aggregated volume

-     Price

 

244,641

Unknown / N/A

e)

Date of the transaction

Transfer occurred on 29 January 2021

f)

Place of the transaction

XLON, AIM

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHJBMFTMTBTBFB